Immune Modulatory Therapies LLC

Eden, NY Doing business as Imod

UEI
J453G5R8UMJ5
CAGE
7F0L2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Veteran Owned Business
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4786 Enser Rd, Eden, NY 14057, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel drug for cancer immunotherapy that targets phosphatidylserine R43CA257721 National Cancer Institute (NIH) $879,529
Reversing/blocking t cell suppression by extracellular vesicles as cancer therapy R43CA224602 National Cancer Institute (NIH) $280,902

Quick answers

Is Immune Modulatory Therapies LLC registered in SAM.gov?

Yes. Immune Modulatory Therapies LLC's SAM.gov registration is active through November 28, 2026.

What is Immune Modulatory Therapies LLC's most recent federal award?

Immune Modulatory Therapies LLC's most recent federal grant award is Novel drug for cancer immunotherapy that targets phosphatidylserine (R43CA257721), from National Cancer Institute (NIH), on March 11, 2021.

On GovTribe

See Immune Modulatory Therapies LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login